NSF Also Plans To Process Proposals On-Line, In Five Years

Within five years, the National Science Foundation hopes to receive a "substantial" number of proposals electronically, according to Alvin Thaler, NSF’s point man for computerizing document transfer. By late fall, Thaler hopes to see a test proposal arrive electronically, complete with tables, equations, diagrams, and photographs. In the meantime about 40,000 proposals a year arrive at NSF, each one (with its copies) about a foot thick. Line them up on a shelf and you have "seven miles

Written bySusan Milius
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

Within five years, the National Science Foundation hopes to receive a "substantial" number of proposals electronically, according to Alvin Thaler, NSF’s point man for computerizing document transfer. By late fall, Thaler hopes to see a test proposal arrive electronically, complete with tables, equations, diagrams, and photographs.

In the meantime about 40,000 proposals a year arrive at NSF, each one (with its copies) about a foot thick. Line them up on a shelf and you have "seven miles of proposals, that’s a long walk," Thaler says.

Less paper, faster processing, captured keystrokes, the benefits of computerization seem obvious, but what’s slowing Thaler down is the nature of U.S. society. "We could have solved this problem very easily by saying everybody has to buy this system, this brand." With the same hardware and software, researchers and program officers could whisk proposals and comments back and forth with ease. However, the United States ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies